共 50 条
- [45] Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase Ib trial CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 4449 - 4459
- [46] A Phase I, Randomised, Double Blind, Placebo Controlled, Study To Assess The Safety, Tolerability And Pharmacokinetics Of Multiple Inhaled Doses Of Rpl554 Administered By Nebuliser To Healthy Male Subjects And Stable COPD Patients AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193